Clinical Trial Update: Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the minimal clinically important difference in symptom relief after pantoprazole treatment in patients with gastroesophageal reflux di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux | Phase 4 | Status: COMPLETED